Baxter appoints dr. david wilkes to its board and albert stroucken as lead independent director

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a leading global medical products company, today announced it has appointed david s. wilkes, m.d., dean, university of virginia school of medicine, and co-founder and chief scientific officer of biotech start-up immuneworks inc., to its board of directors. dr. wilkes will serve on baxter's quality, compliance and technology committee. additionally, baxter has appointed albert p.l. stroucken, former executive chairman and ch
BAX Ratings Summary
BAX Quant Ranking